Emman Suspension (Antimalaria) x80ml

Emman Suspension is an innovative antimalarial medication that combines two powerful active ingredients: piperaquine 640mg and dihydroartemisinin 80mg  for effective malaria treatment. This artemisinin-based combination therapy (ACT) provides fast-acting and long-lasting protection against malaria parasites.

Uses

Emman Suspension treats acute uncomplicated malaria caused by Plasmodium falciparum parasites. It’s also effective against multidrug-resistant strains and can be used for both treatment and prevention of malaria in endemic regions.

Benefits

• Rapid clearance of malaria parasites
• Dual-action mechanism combats resistant strains
• Convenient once-daily dosing
• Short treatment duration (3 days)
• Effective against Plasmodium falciparum
• Liquid suspension format for easy pediatric dosing
• Extended protection against reinfection
• Favorable safety profile compared to older antimalarials

How It Works

Emman Suspension works through complementary mechanisms. Dihydroartemisinin rapidly reduces parasite load by generating free radicals that damage parasite proteins. Piperaquine provides extended antimalarial activity by disrupting parasite digestive vacuole function.

Duration of Action

Dihydroartemisinin acts quickly with a half-life of 1-2 hours. Piperaquine provides extended protection with a half-life of 22-24 days, preventing recurrence and reinfection.

Dosage

Warnings

Complete the full 3-day course of treatment even if symptoms improve. Failure to complete treatment may result in recurrence and contribute to antimalarial resistance. Not recommended for severe malaria requiring intravenous therapy.

Side Effects

Possible side effects include headache, dizziness, loss of appetite, nausea, vomiting, abdominal discomfort, mild fever, weakness, joint pain, and sleep disturbances. Most effects are mild and transient.

Pregnancy and Breastfeeding

Use during first trimester of pregnancy only if potential benefit outweighs risks. Generally considered safe in second and third trimesters. Consult healthcare provider before use during pregnancy or breastfeeding.

Interactions

• Antiarrhythmics (risk of QT prolongation)
• Antipsychotics (increased cardiac risk)
• Certain antibiotics (QT interval effects)
• Antiretrovirals (altered drug levels)
• Anticonvulsants (reduced antimalarial efficacy)
• Grapefruit juice (increased drug concentration)
• Anticoagulants (potential interaction)

Precautions

Take Emman Suspension with food or milk to improve absorption and reduce stomach irritation. Shake well before each use. Store at room temperature away from direct sunlight and moisture. Keep out of reach of children.

Important Information

Emman Suspension should be taken at the same time each day for three consecutive days. Complete the full treatment course even if symptoms improve. Seek immediate medical attention if symptoms worsen or do not improve within 48 hours of starting treatment.